Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

DOW Chemical at the World Drug Delivery & Formulation Summit 2013

Published: Monday, December 10, 2012
Last Updated: Monday, December 10, 2012
Bookmark and Share
The pharmaceutical industry is experiencing a massive paradigm shift as the era of the highly profitable blockbusters comes to a close.

In an attempt to remain competitive, companies are under more pressure than ever to push novel compounds through the development pipeline and so it has been largely left to those in formulation and delivery to optimise their product portfolio using winning business strategies and leading technologies.

Entering its 4th consecutive year, the World Drug Delivery & Formulation Summit informs attendees of leading industry updates, strategies and technologies through technical workshops, case studies and presentations. It equips delegates with the tools and the know-how they need to launch new products, reformulate existing drugs and to remain both patient and regulatory compliant.

The three day summit is structured into three distinct streams that focus on leading issues and challenges in the small molecule, biological and technology space respectively. These include innovative formulation technologies, routes of delivery, advances in drug delivery devices and best practices in supporting the sourcing and management of partnering relationships.

We are thrilled that Dow Chemical will be attending both as our Lead Category Sponsor for Solubilisation and as Chairman for our leading technology day. We look forward to hearing from them during their interactive session on Monday 18th February 2013.

Exclusive sessions include:

•    Preventing the Demise of the Research-driven Pharmaceutical Industry Model
•    Driving Development in Extreme Population Groups – Geriatrics & Paediatrics
•    Evolving Controlled Release Technologies to Support the Next Generation of Drug Delivery
•    Novel Concepts in Pharmaceutical Analysis in Supporting Formulation
•    Understanding and Developing the Science Behind Oral Protein Delivery
•    Optimising the Delivery of Peptide Therapeutics
•    Adopting Open Innovation to Ensure Continued Growth and Success in Pharma Development

For the full programme, visit www.ddfevent.comprogramme.

This summit agenda is researched and produced with the help of drug delivery and formulation experts to reflect the latest industry news, technologies and advancements.  Additionally we facilitate pre-arranged one-to-one meetings onsite between yourselves and leading service and technology providers, hand-picked to suit your personal needs.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Inroads Against Leukemia
Potential for halting disease in molecule isolated from sea sponges.
Researchers Disguise Drugs As Platelets to Target Cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.
A Fundamental Protection Mechanism Against Formalin In Mammals is Revealed
Formaldehyde, or formalin, is well known to all of us as a common chemical used in many industrial processes and also as a preservative, remarkably we also produce formaldehyde in our bodies.
Drug Used To Treat HIV Linked to Lower Bone Mass in Newborns
NIH study finds mothers’ use of tenofovir tied to lower bone mineral content in babies.
Bone Risks Linked to Genetic Variants
A large-scale genomic study uncovered novel genetic variants and led researchers to an unexpected gene that affects bone density and fracture risk.
Combo of 3 Antibiotics Can Kill Deadly Staph Infections
Three antibiotics that, individually, are not effective against a drug-resistant staph infection can kill the deadly pathogen when combined as a trio, according to new research.
Microbe Artwork Shows The Limits Of Antibiotics
An Oxford University research fellow has been creating art using bacteria found in the human gut and harvested from faecal samples.
Urine Excretion From Stem Cell-Derived Kidneys
Researchers report a strategy for enabling urine excretion from kidneys grown from stem cells.
Low Dose Beta-Blockers As Effective As High Dose After a Heart Attack?
Heart attack patients live as long – or even longer – on one-quarter the suggested dose.
Antidepressants Plus Blood-Thinners Slow Down Brain Cancer
EPFL scientists have found that combining antidepressants with anticoagulants slows down brain tumors (gliomas) in mice.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos